|
Fleming, Ronald A; Drees, Jeffrey; Loggie, Brian W et al. (2002) Clinical significance of a NAD(P)H: quinone oxidoreductase 1 polymorphism in patients with disseminated peritoneal cancer receiving intraperitoneal hyperthermic chemotherapy with mitomycin C. Pharmacogenetics 12:31-7
|
|
McQuellon, R P; Loggie, B W; Fleming, R A et al. (2001) Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 27:65-73
|
|
Loggie, B W; Fleming, R A; McQuellon, R P et al. (2001) Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 67:999-1003
|
|
Loggie, B W; Fleming, R A; McQuellon, R P et al. (2000) Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 66:561-8
|
|
Loggie, B W; Fleming, R A; Hosseinian, A A (1997) Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma. Urology 50:446-8
|
|
Loggie, B W; Perini, M; Fleming, R A et al. (1997) Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy. Am Surg 63:137-43
|
|
Chen, M Y; Chiles, C; Loggie, B W et al. (1997) Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery. J Surg Oncol 66:19-23
|
